FORT LAUDERDALE/DAVIE, Fla. – The Greater Miami Chamber of Commerce honored H. Thomas Temple, M.D., as a “Health Care Hero” at its 20th annual Health Care Heroes® Award ceremony, which was held May 9, 2017 at Jungle Island in Miami. Dr. Temple, who is senior vice president of translational research and economic development for Nova Southeastern University (NSU), was the recipient of the Bio-Medical Award for his lifetime of work in this field.
“Dr. Temple is multidimensional—an inventor, a surgeon, a university administrator and a family man,” said NSU President Dr. George Hanbury, who nominated Dr. Temple for the award. “Through all of these roles, his goal is simple—to make a lasting impact on humanity.”
According to the Chamber, the Health Care Heroes® Awards program recognizes individuals, institutions, professionals, students, volunteers and programs, who through their individual or collective actions have made an extraordinary impact in the South Florida health care community.
Health Care Heroes’ acts of heroism represent a display of dedication to excellence in their area of expertise beyond the scope of their jobs. Through their commitment to their profession and community, they serve as an inspiration to others in an effort to improve the quality of health care and discover new ways to assist those in need.
A world-class orthopedic surgeon whose career spans three decades, Dr. Temple specializes in treating both children and adults with bone and soft tissue cancers. His work in orthopedic oncology has focused on sparing limbs for patients with bone tumors and finding alternative ways to treat them without using toxic chemotherapy.
In his work with Nova Southeastern University and Vivex Biomedical, Inc., Dr. Temple has played a key role in multiple biomedical inventions that have made a difference in the lives of people throughout the world, helping them regain the use of their limbs and joints. His key products include the MIAMI (marrow-isolated adult multi-lineage inducible) cell, a type of stem cell derived from adult bone marrow; VIA Graft, used to regenerate bone; BioCartilage, marketed internationally for cartilage repair; VIA Disc, an intervertebral disc cell matrix that restores diseased discs; and a host of other regenerative orthopaedic products. He currently holds 12 patents, all of which have been developed into commercial products to treat patients.
Tracy S. Anderson, CEO of Vivex Biomedical, Inc., regarded Dr. Temple’s award fondly. “We at Vivex are so excited that Dr. Temple has been recognized in this way. He is a mainstay in the Miami community and has been instrumental in changing so many people’s lives. This is a very well deserved honor.”
As NSU’s senior vice president of translational research and economic development, he is responsible for building the connections, resources and entrepreneurial energy for the commercialization of the university’s research activities to foster research that makes a direct impact on people and the environment. He also serves as executive associate dean for research for NSU’s College of Allopathic Medicine (M.D. College). He has already achieved much success, most notably through the creation of the NSU Cell Therapy Institute, an international collaboration with prominent medical research scientists from NSU’s M.D. College and Sweden’s world-renowned Karolinska Institutet (KI), which is focused on conducting pioneering cell-based biomedical research.
His current research efforts are centered around creating and expanding tissue and cell libraries that can be used to develop targeted strategies to treat patients with malignant tumors of the skeletal system.
About Vivex Biomedical, Inc.
Vivex Biomedical, Inc. is a regenerative biologics company, dedicated to creating novel products for patient care. Founded in 2014, Vivex and UMTB (founded 1970) strive for methods to convert translational research into treatments for patients.
Vivex’s primary goal is translating innovation into treatments for patients, further expanding surgical options, and fulfilling surgeon needs. At the present time, research and development is focused on making strides across biologics and regenerative medicine, with major areas of investigation including: cartilage, soft tissue, bone, and skin. Focuses include amniotic fluid therapy, viable allogenic bone allografts, and amniotic tissue matrices.
Vivex works closely with community partners that are committed to providing care and compassion to donor families, while simultaneously inspiring communities to donate. Partnering with others ensures that families are offered the appropriate options and support for donation, including Life Alliance, the Lions Eye Bank, Brain Bank, and Medical Examiners.
About Nova Southeastern University (NSU)
Located in beautiful Fort Lauderdale, Florida, Nova Southeastern University (NSU) is a dynamic research institution dedicated to providing high-quality educational programs at the undergraduate, graduate, and first-professional degree levels. A private, not-for-profit institution, NSU has campuses in Fort Lauderdale, Fort Myers, Jacksonville, Miami, Miramar, Orlando, Palm Beach, and Tampa, Florida, as well as San Juan, Puerto Rico, while maintaining a presence online globally. For more than 50 years, NSU has been awarding degrees in a wide range of fields, while fostering groundbreaking research and an impactful commitment to community. Classified as a research university with “high research activity” by the Carnegie Foundation for the Advancement of Teaching, NSU is 1 of only 50 universities nationwide to also be awarded Carnegie’s Community Engagement Classification, and is also the largest private, not-for-profit institution in the United States that meets the U.S. Department of Education’s criteria as a Hispanic-serving Institution. Please visit www.nova.edu for more information about NSU and realizingpotential.nova.edu for more information on the largest fundraising campaign in NSU history.
May 10, 2017
Jeremy Katzman, M.B.A., APR